معرفی
Dr. Emma Lishman-Walker is a researcher at Newcastle University specializing in molecular oncology with a primary focus on prostate cancer therapeutics and epigenetic mechanisms. Her work centers on identifying novel molecular targets for advanced prostate cancer treatment.
Her research interests encompass:
- Prostate Cancer Pathobiology
- Epigenetic Modifications in Cancer Progression
- Kinase Signaling Pathways
- Therapeutic Target Validation
- Castration-Resistance Mechanisms
- Molecular Drivers of Therapy Resistance
Recent publications demonstrate her expertise in prostate cancer molecular pathways, with 2024 research exploring Casein Kinase 1α as a therapeutic target and 2023 work investigating KMT5A-mediated epigenetic regulation of CDC20. These studies collectively advance understanding of molecular vulnerabilities in treatment-resistant prostate cancer through integrated approaches to kinase signaling and epigenetic control.
۰مقاله منتشرشده
